DMD-AS3

Q-omics provides the consensus-scored DMD-AS3 profile across patient tissues and cancer cell-line models. DMD-AS3 expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, DMD-AS3 RNA expression shows 11,729 significant protein co-abundance associations, with the highest sampling consensus in HNSC. Together, these results highlight BLCA, and HNSC as cancer lineages where DMD-AS3 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes DMD-AS3 survival associations across molecular data types. DMD-AS3 RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

DMD-AS3 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	2	BLCA (126)	view →

This table ranks reproducible DMD-AS3 RNA expression–survival associations across cancer types. High DMD-AS3 expression shows unfavorable associations in BLCA and KIRC. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for DMD-AS3 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.213	0.722	<.001	126	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →

Pink = unfavorable, green = favorable. all 2 lineages →

DMD-AS3-BLCA (OS)

Explore this curve interactively →